Cipla to export new anti-asthma inhaler
India's second-largest drugmaker by market share, Cipla Ltd, expects to start selling a potentially lucrative new asthma treatment in Europe by October, its chairman told a shareholders' meeting
India's second-largest drugmaker by market share, Cipla Ltd, expects to start selling a potentially lucrative new asthma treatment in Europe by October, its chairman told a shareholders' meeting